Entry and the Number of firms in the Swedish Pharmaceuticals Market
This paper analyses the factors that determine entry into the Swedish pharmaceuticals market. The analysis is based on panel data for 22 different substances covering the years 1972 to 1996. The results show that profit opportunities in a particular market have a positive impact on entry. In addition, there is some evidence suggesting that the length of the patent protection period has a negative impact on entry.
|Date of creation:||28 Nov 2000|
|Date of revision:|
|Contact details of provider:|| Postal: Department of Economics, Umeå University, S-901 87 Umeå, Sweden|
Phone: 090 - 786 61 42
Fax: 090 - 77 23 02
Web page: http://www.econ.umu.se/
More information through EDIRC
When requesting a correction, please mention this item's handle: RePEc:hhs:umnees:0541. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (David Skog)
If references are entirely missing, you can add them using this form.